MRNA technical analysis

MRNA Technical Analysis

Analysis date

August 5, 2026

Market

NasdaqGS (USD)

Daily cutoff

August 3, 2026

Reliability

Passed

Informational use only. This page is not investment advice.

Data verification

MRNA Data Verification

Checking the latest completed daily bar for date and closing-price consistency before indicators are calculated.

Symbol
MRNA
Market
NasdaqGS
Currency
USD (US Dollar)
Latest completed bar
August 3, 2026

Historical prices are adjusted for corporate actions when applicable. Date and closing-price consistency checks passed for the latest completed daily bar.

Validation seriesLatest CloseDateDifferenceStatus
Calculation series55.14August 3, 2026-Verified
Verification series55.14August 3, 2026 (previous close)0.00%Verified

Bottom line

MRNA Technical Analysis Summary

MRNA trades at 55.14 as of the August 3, 2026 daily cutoff, down sharply from the July 2026 peak of 85.60 after a 32.59% drop over the last 20 sessions. The daily trend is mixed: price sits below SMA20 (62.41) and SMA50 (58.55) but holds above SMA200 (45.00). Daily RSI14 at 41.34 is neutral to soft, and the MACD histogram is negative at -1.20, so short-term momentum is weak. The weekly picture is also mixed, with price at 54.82 holding just above the weekly SMA20 (54.79) and SMA50 (41.86) but far below SMA200 (82.06), and the weekly MACD histogram has turned slightly negative at -0.40. Key support is at 52.66 (20-day low) with 43.90 (60-day low) below it. Resistance sits at SMA20 (62.41) and SMA50 (58.55), then the 20-day high of 82.90 and the July peak of 85.60.

Multi-timeframe dashboard

Multi-Timeframe Technical Dashboard

Comparing daily (2-year) and weekly (5-year) perspectives to identify aligned or conflicting signals.

Daily (August 3, 2026)

Trend
Mixed. Price at 55.14 is below SMA20 (62.41) and SMA50 (58.55) but above SMA200 (45.00). SMA20 remains above SMA50, and both sit above SMA200, preserving the bullish moving-average structure from the prior advance, even though price has slipped below the short-term averages during the correction.
Momentum
Weak. RSI14 at 41.34 is below the neutral 50 level, showing soft momentum without oversold conditions. MACD at -2.11 is below the signal line at -0.91 with the histogram at -1.20 negative, indicating a downside bias after the pullback from the July high of 85.60.
Volatility
Elevated. ATR14 at 3.93 (7.13% of price) reflects wide daily ranges typical of biotech stocks. Bollinger Bands (47.15 to 77.67) are wide, with price trading in the lower portion of the bands.
Volume
Near average. Latest daily volume of 5,173,500 is 92.9% of the 20-period average (5,566,730), indicating the recent decline has not been accompanied by a surge in participation.

Assessment

The daily chart shows a sharp correction after a strong advance from the late-2025 low of 22.28. Price has fallen below SMA20 and SMA50, RSI is neutral to soft at 41.34, and the MACD histogram is firmly negative. The latest bar gained 0.58% and closed at 55.14, still above the SMA200 (45.00) and the 60-day low of 43.90. A close back above SMA20 (62.41) would be the first sign of stabilization, while a break below 52.66 (20-day low) would put the 60-day low of 43.90 in focus.

Weekly (July 27, 2026 week)

Trend
Mixed. Price at 54.82 is just above SMA20 (54.79) and above SMA50 (41.86), but remains well below SMA200 (82.06). The SMA200 far overhead reflects a long-term downtrend that has not been repaired despite the strong recovery off the 52-week low of 22.28.
Momentum
Neutral. RSI14 at 51.81 is near the neutral 50 level. MACD at 5.20 is below the signal line at 5.61 with the histogram at -0.40 slightly negative, suggesting upside momentum faded after the rally peaked in early July.
Volatility
High. ATR14 at 8.73 (15.93% of price) reflects wide weekly ranges. This is typical of a volatile biotech name undergoing a sharp correction.
Volume
Below average. Weekly volume of 27,162,900 is 79.6% of the 20-week average (34,144,045), suggesting the pullback has unfolded on lighter participation.

Assessment

The weekly chart confirms the correction on the higher timeframe. Price is back near the weekly SMA20 (54.79) after peaking at 85.60 in early July, and the weekly MACD histogram has turned slightly negative. The five-week return of -18.51% shows how quickly the rally has unwound. Price remains above the weekly SMA50 (41.86), so the broader recovery off the 52-week low is still intact, but reclaiming the weekly SMA20 and turning the MACD histogram positive are needed to stabilize the picture.

Key indicators

MRNA Key Technical Indicators

RSI, MACD, moving averages, ATR, and Bollinger Bands across daily and weekly timeframes.

IndicatorDailyWeekly
RSI (14)41.3451.81
MACD (12, 26, 9)-2.11 / -0.91 / -1.205.20 / 5.61 / -0.40
ATR (14)3.93 (7.13%)8.73 (15.93%)
Bollinger Bands (20, 2)47.15 - 77.6737.36 - 72.21
SMA (20)62.4154.79
SMA (50)58.5541.86
SMA (200)45.0082.06

Price structure

MRNA Price Structure and Returns

Price performance across multiple lookback periods and 52-week position.

MetricDailyWeekly
Current Price55.1454.82
1-Period Return+0.58%+1.39%
5-Period Return-0.88%-18.51%
20-Period Return-32.59%+4.30%
60-Period Return+13.02%+99.64%
252-Period Return+86.54%-83.93%
52-Week Low22.2822.28
52-Week High85.6085.60
52-Week Position51.90%51.39%

Key levels

MRNA Support and Resistance Levels

Key price levels based on recent swing highs and lows across daily and weekly timeframes.

LevelDailyWeekly
20-Period High82.9085.60
20-Period Low52.6643.68
60-Period High85.6085.60
60-Period Low43.9022.28

Scenarios

MRNA Technical Scenarios

Conditions, invalidation triggers, and what to watch for each scenario.

Bullish

Trigger

Price reclaims and holds the daily SMA20 (62.41) and SMA50 (58.55), then breaks above the 20-day high of 82.90 toward the July peak of 85.60.

Invalidation

Price breaks below the 60-day low of 43.90.

What to watch

A close back above the daily SMA20 (62.41); the weekly MACD histogram turning positive; RSI crossing back above 50 on the daily.

Range-Bound

Trigger

Price oscillates between the 20-day low of 52.66 and the 20-day high of 82.90, with the daily MACD histogram staying negative and flattening.

Invalidation

A decisive break of either boundary with expanding volume.

What to watch

RSI staying between 35 and 60; the daily MACD histogram not expanding; volume fading near resistance.

Bearish

Trigger

Price closes below the 20-day low of 52.66 and then the 60-day low of 43.90, extending the correction.

Invalidation

Price reclaims and holds above the daily SMA50 (58.55).

What to watch

Sustained closes below 52.66; the daily MACD histogram deepening further negative; the weekly MACD histogram turning more negative; rising downside volume.

Methodology

Methodology and Limitations

This technical analysis is calculated locally from adjusted OHLCV history. The daily series ends August 3, 2026, and the weekly series ends July 27, 2026 week. The latest completed daily bar is independently checked for date and closing-price consistency. Historical prices are adjusted for corporate actions when applicable. Indicators include Wilder RSI(14), MACD(12,26,9), SMA20/50/200, Wilder ATR(14), Bollinger Bands(20,2), relative volume, multi-period returns, and price-range levels. Support and resistance are descriptive zones, not guaranteed reversal points. Historical patterns do not predict future prices, and this page is not investment advice.

Frequently Asked Questions

This technical analysis is for informational and educational purposes only. It does not constitute investment advice, a recommendation, or a solicitation to buy or sell any security. Past performance and historical patterns are not guarantees of future results. All investments carry risk, including the potential loss of principal. Always conduct your own research and consult with a qualified financial advisor before making investment decisions.

Market data is checked for date and closing-price consistency before indicators are calculated. Data cutoffs: daily August 3, 2026, weekly July 27, 2026 week. Generated August 5, 2026.